CCL2 |
P13500
|
C-C motif chemokine ligand 2
|
Signaling
|
0.61 |
0.321 |
0.962 |
CCL5 |
P13501
|
C-C motif chemokine ligand 5
|
Signaling
|
1.8E-03 |
0.403 |
0.885 |
CFH |
P08603
|
complement factor H
|
|
0.86 |
0.441 |
0.885 |
CSF2 |
P04141
|
colony stimulating factor 2
|
Signaling
|
0.83 |
0.330 |
0.962 |
CTLA4 |
P16410
|
cytotoxic T-lymphocyte associated protein 4
|
|
0.94 |
0.369 |
0.923 |
CXCL8 |
P10145
|
C-X-C motif chemokine ligand 8
|
Signaling
|
2.7E-04 |
0.310 |
0.962 |
FLNB |
O75369
|
filamin B
|
|
6.1E-10 |
0.458 |
0.923 |
GATA3 |
P23771
|
GATA binding protein 3
|
|
0.90 |
0.415 |
0.846 |
GEM |
P55040
|
GTP binding protein overexpressed in skeletal muscle
|
|
1.2E-08 |
0.467 |
0.769 |
HLA-A |
P04439
|
major histocompatibility complex, class I, A
|
|
1.3E-03 |
0.370 |
0.846 |
HLA-B |
P01889
|
major histocompatibility complex, class I, B
|
|
3.9E-05 |
0.379 |
0.885 |
HLA-DRB1 |
P01911
|
major histocompatibility complex, class II, DR beta 1
|
Immune response
|
1.1E-03 |
0.333 |
0.923 |
IL10 |
P22301
|
interleukin 10
|
|
5.9E-03 |
0.281 |
0.923 |
IL17A |
Q16552
|
interleukin 17A
|
|
4.3E-02 |
0.324 |
0.923 |
IL17F |
Q96PD4
|
interleukin 17F
|
|
3.9E-02 |
0.480 |
0.808 |
IL1B |
P01584
|
interleukin 1 beta
|
|
0.13 |
0.276 |
0.962 |
IL22 |
Q9GZX6
|
interleukin 22
|
|
1.9E-04 |
0.393 |
0.885 |
IL6 |
P05231
|
interleukin 6
|
|
0.32 |
0.248 |
0.962 |
KIR3DL1 |
P43629
|
killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 1
|
Receptor
|
8.4E-14 |
0.475 |
0.769 |
MICA |
Q29983
|
MHC class I polypeptide-related sequence A
|
|
5.0E-03 |
0.473 |
0.846 |
MYD88 |
Q99836
|
MYD88 innate immune signal transduction adaptor
|
Enzyme modulator
|
0.12 |
0.414 |
0.923 |
NXF1 |
Q9UBU9
|
nuclear RNA export factor 1
|
Nucleic acid binding
|
0.98 |
0.531 |
0.885 |
RBM45 |
Q8IUH3
|
RNA binding motif protein 45
|
|
2.1E-10 |
0.383 |
0.846 |
SEC14L2 |
O76054
|
SEC14 like lipid binding 2
|
|
2.9E-08 |
0.494 |
0.885 |
TLR2 |
O60603
|
toll like receptor 2
|
|
1.0E-06 |
0.361 |
0.923 |